Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,292 | 71,514 | 67,769 | 44,287 | 61,389 |
| Marketable Securities | 65,047 | 52,204 | 72,946 | 84,212 | 74,234 |
| Receivables | 32,410 | 8,392 | 9,738 | 7,725 | 9,149 |
| Inventories | 9,489 | 11,101 | 7,723 | 7,482 | 6,406 |
| TOTAL | $171,772 | $153,090 | $168,442 | $153,329 | $161,321 |
| Non-Current Assets | |||||
| PPE Net | 3,943 | 2,686 | 2,594 | 2,732 | 2,951 |
| Other Non-Current Assets | 6,074 | 2,958 | 3,011 | 3,064 | 1,705 |
| TOTAL | $10,017 | $5,644 | $5,605 | $5,796 | $4,656 |
| Total Assets | $181,789 | $158,734 | $174,047 | $159,125 | $165,977 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,862 | 15,699 | 9,656 | 3,730 | N/A |
| Accounts payable and accrued liabilities | 4,499 | 4,437 | 4,138 | 3,299 | 3,003 |
| Accrued Expenses | 26,792 | 18,926 | 14,821 | 12,813 | 13,961 |
| TOTAL | $62,457 | $44,851 | $35,039 | $26,209 | $24,331 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,971 | 34,094 | 40,098 | 45,985 | 49,860 |
| Deferred Revenues | 9,304 | 5,789 | 6,424 | 6,367 | 7,367 |
| Other Non-Current Liabilities | 4,443 | 3,746 | 3,429 | 3,127 | 3,167 |
| TOTAL | $76,333 | $82,084 | $88,779 | $95,371 | $100,294 |
| Total Liabilities | $138,790 | $126,935 | $123,818 | $121,580 | $124,625 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,061 | 128,014 | 127,772 | 127,260 | 126,704 |
| Common Shares | 128 | 128 | 128 | 127 | 126 |
| Retained earnings | -482,658 | -486,976 | -462,516 | -465,535 | -450,427 |
| Other shareholders' equity | -99 | 0 | -40 | -27 | -41 |
| TOTAL | $42,999 | $31,799 | $50,229 | $37,545 | $41,352 |
| Total Liabilities And Equity | $181,789 | $158,734 | $174,047 | $159,125 | $165,977 |